Network Bio
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- $50M
Investors
- 6
About Network Bio
Established in 2022 and based in California, US, Network Bio is a healthcare AI company that builds generalizable AI models trained on large-scale patient tissue, blood sample, and clinical outcome data to support disease detection, biomarker discovery, and personalized medicine.
Who invested in Network Bio
6 investors across 1 round
See all investors in Network Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 19, 2026
Amount
$50M
Investors
Questions about Network Bio
Who invested in Network Bio?
Network Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Network Bio raised?
Network Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Network Bio last raise money?
Network Bio's most recent round on record is a Series B, in Aug 2026.
What does Network Bio do?
Established in 2022 and based in California, US, Network Bio is a healthcare AI company that builds generalizable AI models trained on large-scale patient tissue, blood sample, and clinical outcome data to support disease detection, biomarker discovery, and personalized medicine.
Where is Network Bio headquartered?
Network Bio is headquartered in Palo Alto, US.
Which VCs invest in companies like Network Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Network Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Network Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.